The Price of Fairness: How Data Defines Value in Independent Dispute Resolution

When Congress passed the No Surprises Act (NSA), it promised fairness: a system where patients were protected from unexpected bills and physicians would be paid a "reasonable" rate for out-of-network emergency care. But fairness, like price, depends entirely on how you measure it.

In the world of payment negotiations, specifically IDR, data determines value and insurers control most of the data.

The Illusion of the Qualified Payment Amount (QPA)

The Qualified Payment Amount (QPA) is supposed to represent the median in-network rate for a given CPT code in a geographic region. In practice, it often reflects something else entirely: a figure derived from incomplete networks, shadow contracts, or bundled rates that drastically understate what comparable providers actually earn.

Because insurers aren't required to publish their methodology, the QPA operates as a black box one that consistently produces results favorable to the payer. For many providers, that single number becomes the foundation of an underpayment they can't easily challenge without outside help.

That's where data transparency becomes the difference between accepting a loss and proving your worth.

Transparency in Coverage: A Window Into the Real Market

Since July 2022, the Transparency in Coverage (TiC) Rule has required payers to publish detailed machine-readable files (MRFs) listing negotiated rates for every CPT code, provider, and plan. In theory, this allows providers to see the true spectrum of fair market values (FMVs) — but in practice, the files are vast, unstructured, and intentionally difficult to interpret.

Each MRF contains terabytes of data, far more information than a standard office computer can handle. Without automation or specialized parsing, it's nearly impossible for an individual physician or billing office to extract actionable insights.

MedRes built its analytics infrastructure to do exactly that. By partnering with companies that process terabytes of TiC data across major payers, MedRes identifies real-world market benchmarks that cut through the QPA's opacity. These datasets let us walk into arbitration not with anecdotes, but with evidence. We counter the insurer's "median" rate, an engineered fiction, with our own transparent and defensible QPA.

From Underpayment to Evidence-Based Recovery

In IDR, data helps support the story.

A provider who walks in with a claim and a story is disadvantaged. A provider who walks in with a story and comparable rate evidence, regional median pricing, and historical award data has leverage. Arbitrators consistently favor submissions that are grounded in objective market data, not broad appeals to fairness.

That's why MedRes treats Fair Market Value as a measurable, defensible number. By combining Transparency in Coverage datasets, CMS fee benchmarks, and prior arbitration precedents, we build the quantitative foundation behind each IDR case. It's not just about claiming that a surgeon deserves more, we have to prove, line by line, that the insurer's own network pays more.

Data as a Strategy, Not a Statistic

The future of reimbursement will belong to those who treat data as leverage. In an environment where QPAs are shrinking and networks are consolidating, the ability to quantify value is what separates independent practices from institutional dependency.

If you're ready to challenge underpayments with evidence-based arbitration, contact us today for a free review of your out-of-network claims and see how much revenue you might be leaving on the table.